← All trials
NCT03631667
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2019
- Primary completion
- Dec 1, 2020
- Completion date
- Dec 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 7
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Oregon State UniversityLead sponsor
- National Institute of Environmental Health Sciences (NIEHS)Collaborator
- Oregon State UniversityReponsible party - principal investigator
- Lawrence Livermore National LaboratoryCollaborator
- Oregon State UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.